Document Type

Article

Journal Title

Nutrients

Publication Date

Fall 11-27-2014

Volume

6

Abstract

Workers exposed to organic dusts from concentrated animal feeding operations (CAFOs) are at risk for developing airway inflammatory diseases. Available preventative and therapeutic measures for alleviating dust-induced lung disease are inadequate. Because omega-3 fatty acids can mitigate inflammatory processes, we aimed to determine whether nutritional supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA) could reduce the airway inflammatory consequences of exposures to organic dust. Aqueous extracts of organic dusts from swine CAFOs (ODE) were utilized. In DHA-pretreated human bronchial epithelial cells, lung fibroblasts, monocyte cell cultures, and precision-cut murine lung slices, we found that DHA pretreatment dose-dependently decreased ODE-induced inflammatory cytokine production. To determine the in vivo significance of DHA, C57BL/6 mice were orally administered DHA for seven days prior to treatment with intranasal ODE or saline inhalations. Animals treated with 2 mg DHA demonstrated significant reductions in ODE-induced bronchial alveolar lavage neutrophil influx and pro-inflammatory cytokine/chemokine production compared to mice exposed to ODE alone. Collectively, these data demonstrate that DHA affects several lung cells to reduce the airway inflammatory response to organic dust exposures. Dietary supplementation with DHA may be an effective therapeutic strategy to reduce the airway inflammatory consequences in individuals exposed to agriculture dust environments.

MeSH Headings

Air Pollutants, Animals, Anti-Inflammatory Agents, Cell Line, Disease Models, Animal, Docosahexaenoic Acids, Dose-Response Relationship, Drug, Dust, Epithelial Cells, Fibroblasts, Humans, Inflammation Mediators, Inhalation Exposure, Intercellular Adhesion Molecule-1, Lung, Male, Mice, Inbred C57BL, Monocytes, Neutrophil Infiltration, Pneumonia, Swine

ISSN

2072-6643

Creative Commons License


This work is licensed under a Creative Commons Attribution 4.0 License.